Simple diabetic patients generally do not need to use ranitidine treatment, if accompanied by peptic ulcer, reflux esophagitis and other diseases can be treated with ranitidine hydrochloride.
Ranitidine is an H2 receptor antagonist, can play a role in inhibiting gastric acid secretion, can be used to treat gastric ulcers, duodenal ulcers, reflux esophagitis, peptic ulcer bleeding and other diseases, so patients with diabetes mellitus alone do not need to use ranitidine treatment, if accompanied by peptic ulcer, reflux esophagitis and other diseases can be used to treat ranitidine hydrochloride.
Adverse reactions such as tachycardia, arthralgia, myalgia, headache, dizziness, somnolence, nausea, vomiting, constipation, and granulocytopenia may occur after the use of the drug.
Diabetic patients who require treatment with ranitidine hydrochloride should be treated with the drug under the supervision of a doctor.